GlassScriptPhysician profile
Sheila Eshraghi
NPI 1205254299
$2,176.75
in general payments reported to CMS, 2019-2025
9 companies · $535 in 2025
The $535 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $78.90 · 2023: $44.22 · 2024: $1,354 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Travel and Lodging: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.69 |
| Travel and Lodging | $930.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,189.34 | 2024 | Penumbra System, Red 72 |
| Stryker Corporation | $448.45 | 2023-2025 | N/A, Na, Sonopet Iq |
| Medtronic, INC. | $231.01 | 2021-2025 | Pipeline |
| Imperative Care, INC | $143.03 | 2025 | Zoom 88-T Large Distal Platform |
| Depuy Synthes Sales INC. | $97.62 | 2025 | Embotrap |
| Cardiva Medical, INC. | $27.59 | 2022 | |
| Asahi Intecc USA, INC. | $17.79 | 2024 | Peripheral Vascular |
| W. L. Gore & Associates, INC. | $16.59 | 2024 | Viatorr Endoprosthesis |
| Scientia Vascular | $5.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Eshraghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.